PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
3100748 | HLA-DR (HLA-DR) | gingivitis | NA | NA | NA | unclassified | |
oral lichen planus and gingivitis did, to a much lesser extent, cause the expression hla-dr antigens by the epithelial cells. | |||||||
3154426 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
the average serum creatinine level during the first 20 days after transplantation was lower in hla-identical siblings than in parental donor transplants, suggesting an early effect of histocompatibility. | |||||||
3154455 | HLA-DR (HLA-DR) | transplantation | Norwegian | NA | NA | unclassified | |
patients who successfully received hla-dr-matched kidneys (cd or lrd) had fewer rejection episodes during the first six months after transplantation. | |||||||
3272814 | HLA-B (HLA-B) | azathioprine | NA | prednisolone | NA | unclassified | |
NA | |||||||
3272814 | HLA-A (HLA-A) | azathioprine | NA | prednisolone | NA | unclassified | |
NA | |||||||
3272814 | HLA-DR (HLA-DR) | azathioprine | NA | prednisolone | NA | unclassified | |
NA | |||||||
3275168 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
in a patient aged 22 years with acute myeloblastic leukaemia during complete remission an allogenic transplant of bone marrow identical in the hla antigen range was rejected despite administration before transplantation of a full marrow-ablating dose of busulphan (16 mg/kg) and severe graft-versus-host disease. | |||||||
3275168 | HLA (HLA) | graft-versus-host disease | NA | NA | NA | unclassified | |
in a patient aged 22 years with acute myeloblastic leukaemia during complete remission an allogenic transplant of bone marrow identical in the hla antigen range was rejected despite administration before transplantation of a full marrow-ablating dose of busulphan (16 mg/kg) and severe graft-versus-host disease. | |||||||
3276059 | HLA-DR (HLA-DR) | transplantation | NA | prednisone | NA | unclassified | |
these findings suggest that csa-pred immunosuppressive therapy allows for successful 1 degree-cad renal allograft transplantation without the need for pretransplant blood transfusion conditioning or matching of donor hla a, b, and dr antigens to recipients. | |||||||
3278421 | HLA (HLA) | transplantation | NA | azathioprine | NA | unclassified | |
we recommend the screening of a donors for the a2 subgroup in both the cadaver-donor and living-related groups, and suggest that the utilization of a2 donors in non-a patients may contribute to the transplantation of group o and highly sensitized patients--and, in some cases, improve the degree of hla matching. |
Copyright 2024